Post by Bristol Myers Squibb

Name: We are driven by an ambitious goal: to address the significant unmet need for systemic sclerosis (SS
Uploaded: 2026-06-17T13:00:00.912Z
Channel: Bristol Myers Squibb
Description: We are driven by an ambitious goal: to address the significant unmet need for systemic sclerosis (SSc) treatments that can alter the disease course without the burden of chronic, immunosuppressive the

1,892,975 followers

We are driven by an ambitious goal: to address the significant unmet need for systemic sclerosis (SSc) treatments that can alter the disease course without the burden of chronic, immunosuppressive therapies. Dedicated to addressing this challenge, we are assessing whether CAR T cell therapy can reset the immune system in people living with SSc, with the ultimate goal of achieving long-term, treatment-free disease control. Learn more about our pioneering cell therapy research in autoimmune diseases: https://lnkd.in/eV9MTizM #SScAwarenessMonth #OneBMS

Video Content